Purpose: The present study aims to describe the differences in the prevalence of EGFR
mutation of lung adenocarcinoma between private and public healthcare institutions …

Methods: A retrospective analysis of EGFR mutation frequency in 350 patients diagnosed
with adenocarcinoma of lung and its association with pathological characteristics was done …

e18506 Background: EGFR represents an important target in the treatment of lung
adenocarcinomas; many anti-EGFR therapies are approved as first line and second-line …

Methods: The data of all patients with lung adenocarcinoma referred to the Molecular
Department of Masih Daneshvari Hospital Laboratory (National Research Institute of …

Background: In the past decade, the association of epidermal growth factor receptor (EGFR)
mutations with response to tyrosine kinase inhibitor “gefitinib” has revolutionized the …

1534 Background: The epidemiological, multicenter prospective study (NCT01185314;
PIONEER) assessed EGFR mutation (M) rates in pts from Asia with newly diagnosed …

Background Epidermal growth factor receptor (EGFR) represents an important molecular
target in the treatment of lung adenocarcinomas; many anti-EGFR therapies are approved …

Background. Incorporation of molecular analysis of the epidermal growth factor receptor
(EGFR) gene into routine clinical practice represents a milestone for personalized therapy of …

Objective: To investigate the associations of the mutation status of epidermal growth factor
receptor (EGFR) with the factors including gender, age, smoking status, family history and …

Introduction: Adenocarcinoma is the most common type of non-small cell lung cancer
(NSCLC) causing genetic mutations. The most common gene mutations associated with …